Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Postimplantation Syndrome in EVAR
NCT06044480Phase 4Not yet recruiting
- Sponsor
- Centro Hospitalar Universitário de Lisboa Central
- Start
- Nov 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of dexamethasone in Post-implantation syndrome (PIS), sponsored by Centro Hospitalar Universitário de Lisboa Central. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
Post-implantation syndrome (PIS)
Beyond the preview
Go deeper on NCT06044480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06044480.